Extended Data Fig. 7: Kaplan Meier curves for overall survival in breast cancer patients with leptomeningeal disease by breast cancer subtype. | Nature Medicine

Extended Data Fig. 7: Kaplan Meier curves for overall survival in breast cancer patients with leptomeningeal disease by breast cancer subtype.

From: Patritumab deruxtecan in leptomeningeal metastatic disease of solid tumors: the phase 2 TUXEDO-3 trial

Extended Data Fig. 7

Twelve out of the 20 participants in cohort 3 had breast cancer. In 3 of these 12 participants with breast cancer, the expression of hormonal receptors and HER2 could not be evaluated. Shaded areas represent 95% CI. CI: Confidence interval, HER2: Human epidermal growth factor receptor 2, mOS: median overall survival, NA: Not achieved, OS: Overall survival, TNBC: Triple-negative breast cancer.

Back to article page